Insmed Inc. buy Royal Bank of Canada
Start price
14.04.26
/
50%
€129.60
Target price
14.04.27
-
Performance (%)
-5.29%
Price
17.04.26
€120.36
Summary
This prediction is currently active. With a performance of -5.29%, the BUY prediction by Royal_Bank_of_Canada is trending in the wrong direction. This prediction currently runs until 14.04.27. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Insmed Inc. | -5.29% |
| iShares Core DAX® | 3.593% |
| iShares Nasdaq 100 | 5.810% |
| iShares Nikkei 225® | 4.075% |
| iShares S&P 500 | 4.142% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Insmed Inc. diskutieren
Insmed (INSM) had its "outperform" rating reaffirmed by Royal Bank Of Canada.
Ratings data for INSM provided by MarketBeat